Are you Dr. Gyurkocza?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000Fax+1 212-639-5301
Summary
- Dr. Boglarka Gyurkocza, MD is an oncologist in Seattle, Washington. She is currently licensed to practice medicine in Washington, Florida, and New Jersey. She is affiliated with Fred Hutch Cancer Center and is an Instructor at University of Washington School of Medicine.
Education & Training
UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 2003 - 2006
Westchester Medical CenterResidency, Internal Medicine, 2000 - 2003
Semmelweis UniversityClass of 1999
Certifications & Licensure
FL State Medical License 2022 - Present
WA State Medical License 2006 - 2026
NJ State Medical License 2021 - 2025
NY State Medical License 2013 - 2025
MA State Medical License 2006 - 2007- American Board of Internal Medicine Hematology
Clinical Trials
- Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia Start of enrollment: 2009 Feb 01
- Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant Start of enrollment: 2011 Jan 25
- Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia Start of enrollment: 2016 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Randomized Phase III SIERRA Trial ofI-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, Hannah Choe, Mark R Litzow
Journal of Clinical Oncology. 2024-09-19 - Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis.William T Johnson, Zachary D Epstein-Peterson, Nivetha Ganesan, Timothy Pak, Tiffany Chang
Haematologica. 2024-09-01 - 6 citationsRacial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation.Warren B Fingrut, Eric Davis, Anne Archer, Samantha Brown, Sean Devlin
Blood Advances. 2024-06-11
Press Mentions
Bringing Transplant to More Patients with AMLFebruary 25th, 2020
